Latin America Pharmaceutical Products CMO Market | Coherent Market Insights - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Latin America Pharmaceutical Products CMO Market | Coherent Market Insights

Description:

Read here the latest updates on the Latin America Pharmaceutical Products CMO Market published by CMI team. – PowerPoint PPT presentation

Number of Views:26

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Latin America Pharmaceutical Products CMO Market | Coherent Market Insights


1
Coherent Marketing Insights
  • Market Research Business Consulting Services
  • https//www.coherentmarketinsights.com/
  • Covid-19 Impact Tracker

2
  • LATIN AMERICA PHARMACEUTICAL PRODUCTS CMO MARKET
    ANALYSIS
  • Latin America Pharmaceutical Products CMO Market,
    By Product Type (API and Ingredients, Finished
    Dosage Form, Pharmaceutical Packaging), By
    Country (Brazil, Mexico, Argentina, Rest of Latin
    America) - Size, Share, Outlook, and Opportunity
    Analysis, 2020 - 2027
  • The demand for generic products is high in the
    pharmaceutical market in Latin America. Moreover,
    majority of pharmaceutical companies are
    gradually outsourcing manufacturing activities to
    contract manufacturing organizations (CMO).

3
  • Statistics
  • Latin America Pharmaceutical Products CMO Market
    is estimated to account for US 13,266.5 Mn in
    terms of value by the end of 2027.
  • Latin America Pharmaceutical Products CMO Market
    DriversIncreasing prevalence of chronic
    disorders is expected to propel growth of Latin
    America Pharmaceutical Products CMO Market over
    the forecast period. For instance, according to
    Incidência de Câncer no Brasil, the estimated
    number of new cases of cancer was 600,000,
    excluding cases of non-melanoma skin cancer
    during 2018-2019 biennium, in Brazil.
  • Moreover, increasing vaccination drives are also
    expected to aid in growth of the market. For
    instance, in March 2020, Brazil initiated its
    National Flu Vaccination Campaign in three phases
    against influenza. The vaccine is indicated for
    anyone over 6 months of age, except those who
    have had allergic reactions at previous doses.

4
  • Statistics
  • Brazil held dominant position in Latin America
    Pharmaceutical Products CMO Market in 2019,
    accounting for 38.6 share in terms of value,
    followed by Mexico and Argentina, respectively
  • Figure 1 Latin America Pharmaceutical Products
    CMO Market Share () Value, By Region, 2019

5
  • Latin America Pharmaceutical Products CMO Market
    Restraints
  • The pharmaceutical industry in Mexico does not
    operate through an established system of
    reimbursement and there is minimal reimbursement
    offered outside the hospital setting.
    Reimbursement is limited to generic drugs, based
    on health technology assessment and to the under
    privileged population. Such scenario is expected
    to hinder growth of Latin America Pharmaceutical
    Products CMO Market.
  • Weak or ambiguity in patent laws is also expected
    to limit growth of the market. Different
    countries in Latin America have adopted different
    approaches for intellectual property protection.
    Ambiguity also prevails regarding pricing of
    drugs. For instance, prices of public sector
    pharmaceutical drugs in Latin America varied than
    those sold through the private sector.

6
Latin America Pharmaceutical Products CMO Market
Report Coverage

7
Latin America Pharmaceutical Products CMO Market
Opportunities
  • Growing medical tourism in Latin America is
    expected to offer lucrative growth opportunities
    for players in the market. For instance,
    according to Tourism of the Federal District,
    Mexico City, in 2018, Tijuana received 1.7
    million patients and companions from the U.S. and
    Canada generating a revenue of US 600 million.
  • Moreover, integration of public and private
    healthcare sector in Latin America may lead to
    revival of a weak sector in the region, thereby
    aiding in growth of the market.
  • Statistics
  • Latin America Pharmaceutical Products CMO Market
    was valued at US 13,266.5 Mn in 2019 and is
    forecast to reach a value of US 40,070.3 Mn by
    2027 at a CAGR of 14.8 between 2020 and 2027.

8
Figure 2 Latin America Pharmaceutical Products
CMO Market Value (US Mn), 2016 - 2027

9
Market Trends/Key Takeaways
  • Major pharmaceutical companies are focused on
    approval and launch of COVID-19 test kits. For
    instance, in February 2020, Osang Healthcare
    received European certification (CE-IVD) for
    GeneFinder, a test kit for the new coronavirus,
    and the company has commercialized the product in
    Italy, Romania, Morocco, Brazil, and Russia.
  • The coronavirus pandemic has adversely impacted
    the healthcare system in Latin America. As of May
    07, 2020, there have been 26,025 confirmed cases
    of COVID-19 with 2,507 deaths in Mexico as
    reported to the World Health Organization. The
    lockdown implemented in several countries in
    Latin America is expected to have mixed impact on
    the market.

10
Figure 3 Value Chain Analysis -

11
  • Latin America Pharmaceutical Products CMO Market
    Competitive Landscape
  • Major players operating in Latin America
    Pharmaceutical Products CMO Market include, BASF
    SE, Bayer AG, Boehringer Ingelheim GmbH, F.
    Hoffmann-La Roche Ltd., Merck Co., Inc.,
    Novartis AG, Pfizer, Inc., Pisa Farmacéutica,
    Fresenius SE Co. KGaA, Takeda Pharmaceutical
    Company Limited, Ferring Pharmaceuticals, Inc.,
    and Landsteiner Scientific.
  • Latin America Pharmaceutical Products CMO Market
    Key DevelopmentsMajor players in the market are
    focused on adopting partnership strategies to
    enhance their market share. For instance, in
    March 2019, Pfizer, Inc. partnered with Unión
    Latinoamerica Contra el Cáncer de la Mujer -
    Latin American Union Against Cancer of Women, to
    launch the personal guide Me and Metastatic
    Breast Cancer.Major players in the market are
    also focused on RD of new products to expand
    their product portfolio. For instance, in
    December 2019, FerGene, a new gene therapy
    company formed as an alliance between Ferring
    Pharmaceuticals and Blackstone Life Sciences,
    announced positive results from a clinical trial
    that assessed the efficacy of nadofaragene
    firadenovec (rAd-IFN/Syn3), an investigational
    gene therapy, for the treatment of high-grade,
    Bacillus Calmette-Guérin unresponsive non-muscle
    invasive bladder cancer.

12
  • Request Sample Report
  • Request Customization
  • Download PDF Brochure
  • Talk to Analyst
  • Referance https//www.coherentmarketinsights.com/
    market-insight/latin-america-pharmaceutical-produc
    ts-cmo-market-3933

13
About Us
  • Coherent Market Insights is a global market
    intelligence and consulting organization focused
    on assisting our plethora of clients achieve
    transformational growth by helping them make
    critical business decisions. We are headquartered
    in India, having office at global financial
    capital in the U.S. Our client base includes
    players from across all business verticals in
    over 150 countries worldwide.
  • What We ProvideCustomized Market Research
    AnalysisIndustry Analysis ServicesBusiness
    Consulting ServicesLong Term Engagement
    ModelCountry Specific Analysis

14
Contact Us
  • Mr. Shah
  • Coherent Market Insights Pvt. LTD.Coherent
    Market Insights 1001 4th Ave, 3200 Seattle, WA
    98154, U.S.Phone 1-206-701-6702
  • Email sales_at_coherentmarketinsights.com

15
Thank You
  • Kindly Follow CMI Social Media Profiles for the
    latest Company Updates.
  • Facebook
  • Linkedin
  • Twitter
  • https//www.coherentmarketinsights.com/
About PowerShow.com